Tonix Pharmaceuticals (TNXP) Insider Trading & Ownership $0.24 +0.00 (+0.21%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Tonix Pharmaceuticals (NASDAQ:TNXP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$58,200.00Number OfInsiders Selling(Last 3 Years)0 Get TNXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Tonix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TNXP Insider Buying and Selling by Quarter Tonix Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/29/2022Seth LedermanCEOBuy100$342.00$34,200.00 3/25/2022Seth LedermanCEOBuy500$48.00$24,000.00 (Data available from 1/1/2013 forward) TNXP Insider Trading Activity - Frequently Asked Questions Who is on Tonix Pharmaceuticals's Insider Roster? The list of insiders at Tonix Pharmaceuticals includes Seth Lederman. Learn more on insiders at TNXP. What percentage of Tonix Pharmaceuticals stock is owned by insiders? 0.04% of Tonix Pharmaceuticals stock is owned by insiders. Learn more on TNXP's insider holdings. Tonix Pharmaceuticals Key ExecutivesDr. Seth Lederman M.D. (Age 66)Co-Founder, President, CEO & Chairman Compensation: $675kMr. Bradley Saenger CPA (Age 50)CFO & Treasurer Compensation: $640.77kMrs. Jessica Edgar MorrisChief Operating OfficerDr. Gregory M. Sullivan M.D. (Age 58)Chief Medical Officer & Secretary Compensation: $661.44kDr. Herbert W. Harris M.D.Ph.D., Executive Vice President of Translational MedicineMs. Siobhan Fogarty B.Sc.M.Sc., Executive Vice President of Product DevelopmentDr. Darryl Rideout Ph.D.Executive Vice President of Experimental ChemistryDr. Sina Bavari Ph.D.Executive Vice President of Infectious Disease Research & DevelopmentDr. Zeil Rosenberg M.D.M.P.H., Executive Vice President of MedicalMr. Thomas Englese (Age 50)Executive Vice President of Commercial Operations More Insider Trading Tools from MarketBeat Related Companies NLTX Insider Transactions ZNTL Insider Transactions CRDF Insider Transactions ACRS Insider Transactions LYEL Insider Transactions SCPH Insider Transactions ALEC Insider Transactions ACRV Insider Transactions ADCT Insider Transactions CHRS Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:TNXP) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNXP Stock Alerts